Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 23;59(2):220.
doi: 10.3390/medicina59020220.

The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center

Cosmin Ioan Faur  1 , Mădălina Anca Moldovan  1 , Mădălina Văleanu  2 , Horațiu Rotar  1 , Laura Filip  1 , Rareș Călin Roman  1
Affiliations

The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center

Cosmin Ioan Faur et al. Medicina (Kaunas). .

Abstract

Background and Objectives: An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. Materials and Methods: We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients' features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. Results: Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. Conclusion: The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options.

Keywords: head and neck cancer; hospitalization costs; non-melanoma skin cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Year distribution of the skin cancer patients.
Figure 2
Figure 2
Correlation between tumor location and type of reconstruction used to repair the surgical defect.
Figure 3
Figure 3
Correlation between tumor stage and time required to perform surgery.
Figure 4
Figure 4
Correlation between tumor stage and days of hospitalization.
Figure 5
Figure 5
Correlation between days of hospitalization and type of reconstruction.
Figure 6
Figure 6
Correlation between days of hospitalization and ASA risk.
Figure 7
Figure 7
Direct treatment costs of NMSC: (a) total costs/5 years for SCC and BCC; (b) the increasing NMSC treatment costs/episode during 5 years of analysis; (c) the increasing BCC and SCC treatment costs/episode during 5 years of analysis.
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Eisemann N., Waldmann A., Geller A.C., Weinstock M.A., Volkmer B., Greinert R., Breitbart E.W., Katalinic A. Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on Incidence. J. Investig. Dermatol. 2014;134:43–50. doi: 10.1038/jid.2013.304. - DOI - PubMed
    1. Cancer.Net Editorial Board. Skin Cancer (Non-Melanoma): Statistics. [(accessed on 1 October 2022)]. Available online: https://www.cancer.net/cancer-types/skin-cancer-non-melanoma/statistics.
    1. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 2012;166:1069–1080. doi: 10.1111/j.1365-2133.2012.10830.x. - DOI - PubMed
    1. Fijałkowska M., Koziej M., Antoszewski B. Detailed Head Localization and Incidence of Skin Cancers. Sci. Rep. 2021;11:12391. doi: 10.1038/s41598-021-91942-5. - DOI - PMC - PubMed